UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors

Journal for immunotherapy of cancer, 2018-12, Vol.6 (1), p.157-157, Article 157

Maleki Vareki, Saman

2018

Link zum Volltext

Verfügbarkeit prüfen

Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis

Cancer treatment reviews, 2021-01, Vol.92, p.102134, Article 102134

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges

JNCI : Journal of the National Cancer Institute, 2021-07, Vol.113 (7), p.823-832

2021

Link zum Volltext

Verfügbarkeit prüfen

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Clinical cancer research, 2017-02, Vol.23 (4), p.1068-1079

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy

Cells (Basel, Switzerland), 2021-05, Vol.10 (5), p.1170

2021

Link zum Volltext

Verfügbarkeit prüfen

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy

Cancers, 2022-03, Vol.14 (6), p.1580

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines

PloS one, 2018-01, Vol.13 (1), p.e0191766

2018

Link zum Volltext

Verfügbarkeit prüfen

CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity

European journal of immunology, 2020-05, Vol.50 (5), p.695-704

2020

Link zum Volltext

Verfügbarkeit prüfen

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma

Therapeutic Advances in Medical Oncology, 2022, Vol.14, p.175883592211227-17588359221122714

2022

Link zum Volltext

Verfügbarkeit prüfen

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma

Journal of translational medicine, 2019-11, Vol.17 (1), p.386-386, Article 386

2019

Link zum Volltext

Verfügbarkeit prüfen

Emerging Biomarker-Guided Therapies in Prostate Cancer

Current oncology (Toronto), 2022-07, Vol.29 (7), p.5054-5076

2022

Link zum Volltext

Verfügbarkeit prüfen

BIOMARKERS OF RESPONSE TO PD-1/PD-L1 INHIBITION

Critical reviews in oncology/hematology, 2017-08, Vol.116, p.116-124

2017

Link zum Volltext

Verfügbarkeit prüfen

TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer

International journal of molecular sciences, 2021-12, Vol.23 (1), p.250

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy

Cancers, 2023-02, Vol.15 (4), p.1300

2023

Link zum Volltext

Verfügbarkeit prüfen

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells

PloS one, 2015-11, Vol.10 (11), p.e0143435-e0143435

2015

Link zum Volltext

Verfügbarkeit prüfen

Loss of Thymine DNA Glycosylase Causes Dysregulation of Bile Acid Homeostasis and Hepatocellular Carcinoma

Cell reports (Cambridge), 2020-04, Vol.31 (1), p.107475-107475, Article 107475

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulation in Pancreatic Cancer

Cancers, 2020-11, Vol.12 (11), p.3340

2020

Link zum Volltext

Verfügbarkeit prüfen

Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma

Current oncology (Toronto), 2022-07, Vol.29 (8), p.5426-5441

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of dynamic microbiota signatures in patients with melanoma receiving ICIs: opportunities and challenges

Nature reviews. Clinical oncology, 2024-06, Vol.21 (6), p.405-406

2024

Link zum Volltext

Verfügbarkeit prüfen

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer

Cancers, 2022-07, Vol.14 (15), p.3563

2022

Link zum Volltext

Verfügbarkeit prüfen

CD1d‐independent activation of mouse and human iNKT cells by bacterial superantigens

Immunology and cell biology, 2012-08, Vol.90 (7), p.699-709

2012

Link zum Volltext

Verfügbarkeit prüfen

IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype

The Journal of immunology (1950), 2023-05, Vol.210 (10), p.1598-1606

2023

Link zum Volltext

Verfügbarkeit prüfen

An adjunct microbiome therapy to enhance immunotherapy efficacy in melanoma patients

Genes and immunity, 2024-02, Vol.25 (1), p.87-88

2024

Link zum Volltext

Verfügbarkeit prüfen

Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases

Physics and imaging in radiation oncology, 2022-01, Vol.21, p.115-122

2022

Link zum Volltext

Verfügbarkeit prüfen

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Oncotarget, 2016-07, Vol.7 (27), p.41363-41379

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(61)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(5)
Cancers
(4)
Oncotarget
(4)
Clinical Cancer Research
(2)
Current Oncology
(2)
Immunology And Cell Biology
(2)
Journal Of Research In Medical Sciences
(2)
Molecular Cancer Therapeutics
(2)
Nature Medicine
(2)
Plos One
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors

Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis

Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines

CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma

Emerging Biomarker-Guided Therapies in Prostate Cancer

BIOMARKERS OF RESPONSE TO PD-1/PD-L1 INHIBITION

TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer

The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells

Loss of Thymine DNA Glycosylase Causes Dysregulation of Bile Acid Homeostasis and Hepatocellular Carcinoma

Immunomodulation in Pancreatic Cancer

Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma

Identification of dynamic microbiota signatures in patients with melanoma receiving ICIs: opportunities and challenges

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer

CD1d‐independent activation of mouse and human iNKT cells by bacterial superantigens

IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype

An adjunct microbiome therapy to enhance immunotherapy efficacy in melanoma patients

Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Suchergebnisse filtern